| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/26/2006 | WO2006008142A1 Diagnosis and therapy of psoriasis vulgaris |
| 01/26/2006 | WO2006008126A2 Novel use of the kinases rsk4 and pak5 |
| 01/26/2006 | WO2006008009A2 Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6) |
| 01/26/2006 | WO2006008008A2 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 01/26/2006 | WO2006008003A2 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 01/26/2006 | WO2006007937A1 Methods and assays for detecting guanylate cyclase activity |
| 01/26/2006 | WO2006007869A1 Monitoring heart failure |
| 01/26/2006 | WO2006007857A1 Bilf1, a constitutive active g-protein coupled receptor |
| 01/26/2006 | WO2006007854A1 Gus3 neuropeptides for regulating hypothalamic function |
| 01/26/2006 | WO2006007841A2 Heat-induced antigen retrieval methods and compositions therefor |
| 01/26/2006 | WO2006007752A1 Method to identify or evaluate compounds useful in the field of fragrances and aromas |
| 01/26/2006 | WO2005116652A3 Method for in vitro diagnosis of sjörgen’s syndrome and lupus |
| 01/26/2006 | WO2005116642A3 Processing of particles |
| 01/26/2006 | WO2005116623A3 Point of care heparin determination system |
| 01/26/2006 | WO2005114164A3 Voltammetric systems for assaying biological analytes |
| 01/26/2006 | WO2005111602A3 Multi-sensor system for fluid monitoring with selective exposure of sensors |
| 01/26/2006 | WO2005111601A3 Fluid treatment apparatus with input and output fluid sensing |
| 01/26/2006 | WO2005103654A3 Method for identification of compounds active in hiv virus replication |
| 01/26/2006 | WO2005102396A3 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 01/26/2006 | WO2005090967A3 The use of gametes and pre-implanted embryos for determining the toxicity of biologically active compounds |
| 01/26/2006 | WO2005086891A9 Classification of breast cancer patients using a combination of clinical criteria and informative genesets |
| 01/26/2006 | WO2005086595A3 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 01/26/2006 | WO2005085865A3 Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb) |
| 01/26/2006 | WO2005082398A3 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells |
| 01/26/2006 | WO2005080565A8 Dna array for analyzing dna methylation, method of constructing the same and mehtod of analyzing dna methylaion |
| 01/26/2006 | WO2005079458A3 ENHANCEMENT OF Th2-DEPENDENT AND INFLAMMATORY RESPONSE |
| 01/26/2006 | WO2005079316A3 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
| 01/26/2006 | WO2005077040A3 Compositions and methods for treating amyotrophic lateral sclerosis (als) |
| 01/26/2006 | WO2005076995A3 Method of measurement of nucleated red blood cells |
| 01/26/2006 | WO2005076007A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y12 (p2y12) |
| 01/26/2006 | WO2005075986A3 Method and kit for the measurement of neutrophil cell activation |
| 01/26/2006 | WO2005075973A3 Acousto-mechanical detection systems and methods of use |
| 01/26/2006 | WO2005069891A3 System and method for expression proteomics based on isotope ratio modification |
| 01/26/2006 | WO2005055808A3 Compositions and methods to diagnose and treat lung cancer |
| 01/26/2006 | WO2005052130A3 Nrbps as modifiers of the rac pathway and methods of use |
| 01/26/2006 | WO2005027727A3 Use of pin1 inhibitors for treatment of cancer |
| 01/26/2006 | WO2005017119A3 Ups as modifiers of the beta catenin pathway and methods of use |
| 01/26/2006 | WO2005017109A3 Nucleic acids and polypeptides required for cell survival in the absence of rb |
| 01/26/2006 | WO2005016230A3 Evaluating protein signatures |
| 01/26/2006 | WO2005012872A3 Liquid crystal based analyte detection |
| 01/26/2006 | WO2004104178A3 Efficient haploid cell sorting for flow cytometer systems |
| 01/26/2006 | WO2004104164A3 Method and apparatus for preparing cell samples for intracellular antigen detection using flow cytometry |
| 01/26/2006 | WO2004076636A3 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 01/26/2006 | WO2004045532A3 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 01/26/2006 | WO2004033059A3 Methods and apparatus for optophoretic diagnosis of cells and particles |
| 01/26/2006 | WO2004014319A3 Screening strategy for anticancer drugs |
| 01/26/2006 | WO2002063032A9 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 01/26/2006 | US20060021074 Reducing the risk of human anti-human antibodies through V gene manipulation |
| 01/26/2006 | US20060020427 Systems and methods for fluid quality monitoring using portable sensors in connection with supply and service entities |
| 01/26/2006 | US20060020398 Integration of gene expression data and non-gene data |
| 01/26/2006 | US20060020396 Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| 01/26/2006 | US20060020394 Network |
| 01/26/2006 | US20060020393 Methods for quantification and de novo polypeptide sequencing by mass spectrometry |
| 01/26/2006 | US20060020392 CrystalSym process |
| 01/26/2006 | US20060020391 Method for tracking and controlling infections |
| 01/26/2006 | US20060020119 Monoclonal antibodies to gastrin hormone |
| 01/26/2006 | US20060020113 Human Six Transmembrane Epithelial Antigen of the Prostate (STEAP) protein; folds in a "serpentine" manner into three extracellular and two intracellular loops; used for diagnosis and treatment of prostate cancer |
| 01/26/2006 | US20060020112 polynucleotide encoding coiled-coil domain of the Stat protein and the first three-strands of the DNA-binding domain of the Stat protein; cell expressing said polynucleotide |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060019915 Method to modulate the immune system with a novel guanine nucleotide exchange factor |
| 01/26/2006 | US20060019910 Inhibiting c Jun amino terminal kinase signal transduction pathway; reducing tumor necrosis factor alpha induced lipolysis |
| 01/26/2006 | US20060019899 EphA2 T-cell epitopes and uses therefor |
| 01/26/2006 | US20060019410 Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
| 01/26/2006 | US20060019409 Spectroscopic methods for component particle analysis |
| 01/26/2006 | US20060019408 Optical biosensors and methods of use thereof |
| 01/26/2006 | US20060019407 ELISA; includes flow-through unit including outer seal, bed support, inner seal, and packed non-porous bed, releasably attached to aspiration pump which enables controlled flow rate; fluid tight; hypodermic needles |
| 01/26/2006 | US20060019406 Lateral flow device for the detection of large pathogens |
| 01/26/2006 | US20060019405 Cat lavator comprising an urine test |
| 01/26/2006 | US20060019403 Method for determining the oxygen demand of an aqueous solution for a purification process |
| 01/26/2006 | US20060019401 Monitoring the stability of vinylog compounds |
| 01/26/2006 | US20060019400 Method for the determination of glucuronides in physiological samples |
| 01/26/2006 | US20060019399 Devices and methods for correlated analysis of multiple protein or peptide samples |
| 01/26/2006 | US20060019398 Method and system for molecular array scanner calibration |
| 01/26/2006 | US20060019373 Biosensor with rf signal transmission |
| 01/26/2006 | US20060019365 IKK-alpha proteins, nucleic acids and methods |
| 01/26/2006 | US20060019349 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 01/26/2006 | US20060019345 Human GABAb receptor 1 promoters |
| 01/26/2006 | US20060019344 C-erbB-2 external domain: gp75 |
| 01/26/2006 | US20060019332 Deparaffinization compositions for dewaxing tissue specimens |
| 01/26/2006 | US20060019330 Combining test sample and the Staphylococcus aureus reactant wherein the test sample results in a change of at least one physical property detectable by a horizontal surface acoustical wave biosensor if Staphylococcus aureus is present; detecting change with the shear horizontal surface wave biosensor |
| 01/26/2006 | US20060019329 Method of screening for protein inhibitors and activators |
| 01/26/2006 | US20060019326 evaluation carried out in three-dimensional tissue-engineered systems, where drug toxicity, metabolism, interaction and/or efficacy can be determined |
| 01/26/2006 | US20060019325 Screening assay |
| 01/26/2006 | US20060019324 PknB kinase and pstP phosphatase and methods of identifying inhibitory substances |
| 01/26/2006 | US20060019323 Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase |
| 01/26/2006 | US20060019322 Nucleotide sequence coding polypeptide for use in diagnosis and therapy of prostate cancer |
| 01/26/2006 | US20060019321 Planar optical waveguide based sandwich assay sensors and processes for the detection of biological targets including early detection of cancers |
| 01/26/2006 | US20060019320 Wnt mediated erbb signalling, compositions and uses related thereto |
| 01/26/2006 | US20060019319 Methods and apparatuses for conducting assays |
| 01/26/2006 | US20060019318 Conformational and topological protein regulation |
| 01/26/2006 | US20060019317 Assay systems and methods for detecting molecules that interact with membrane channels |
| 01/26/2006 | US20060019315 Multimarker panel for diabetes type 1 and 2 |
| 01/26/2006 | US20060019314 Increasing life span by modulation of Smek |
| 01/26/2006 | US20060019313 Method for detecting molecular surface interactions |
| 01/26/2006 | US20060019312 CIS-interactions between MHC molecules and co-expressed proteins, related neurological and non-neurological disorders and related therapeutic/diagnostic utilities |
| 01/26/2006 | US20060019311 Process for detecting PrP using a macrocyclic adjuvant ligand |
| 01/26/2006 | US20060019310 Cell regulatory genes, encoded products, and uses related thereto |
| 01/26/2006 | US20060019308 CD38 modulated chemotaxis |
| 01/26/2006 | US20060019307 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/26/2006 | US20060019302 contacting a biological sample with a solution comprising moving a curved surface wetted with a solution in proximity to the biological sample whereby the distance separating the wetted curved surface and the sample is sufficient to form a moving liquid meniscus layer between the two |